Key Points
- Mohammed Jiwan, a director of Zentek Ltd., purchased 11,000 shares on Dec. 31 at C$0.93 each (C$10,230), increasing his direct ownership to 22,000 shares — a 100% increase.
- Shares opened at C$0.89 and were trading down about 2.2%; the stock's 50‑day/200‑day SMAs are C$1.06/C$1.19, 52‑week range is C$0.85–C$2.50, market cap ≈C$95.5M, P/E is negative (-9.89) and debt‑to‑equity is high (4.97).
- Zentek focuses on research and development of graphene and related nanomaterials, producing graphene‑based antimicrobial coatings, PPE, diagnostics and pharmaceutical products, and wholly owns the Albany graphite project in Northern Ontario.
Zentek Ltd. (CVE:ZEN - Get Free Report) Director Mohammed Jiwan purchased 11,000 shares of the business's stock in a transaction dated Wednesday, December 31st. The shares were purchased at an average cost of C$0.93 per share, with a total value of C$10,230.00. Following the completion of the purchase, the director directly owned 22,000 shares in the company, valued at approximately C$20,460. This represents a 100.00% increase in their ownership of the stock.
Zentek Trading Down 2.2%
Shares of CVE ZEN opened at C$0.89 on Thursday. The business has a 50 day simple moving average of C$1.06 and a 200 day simple moving average of C$1.19. Zentek Ltd. has a 52 week low of C$0.85 and a 52 week high of C$2.50. The stock has a market cap of C$95.50 million, a price-to-earnings ratio of -9.89 and a beta of 0.42. The company has a debt-to-equity ratio of 4.97, a quick ratio of 7.59 and a current ratio of 2.06.
Zentek Company Profile
(
Get Free Report)
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
